Released Aug 8, 2016, after the close
10-Q filed Aug 9, 2016, 40 days after period end · 0001162194-16-000224
Q2 2016 · 10-Q
Revenue$28.17M$28.17M −1.6% vs Q2 2015−2.9% vs Q1 2016
Net Income-$18.62M-$18.62M N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.64-$0.64 N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$18,142,000N/M
Operating Cash Flowderived-$7,354,000N/M
Free Cash Flowderived-$8,872,000N/M
Margins · derived
Operating margin-64.4%−13.2 pt vs Q2 2015
Net margin-66.1%−12.9 pt vs Q2 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $28.17M | $28.62M | $27.61M | $17.48M |
| Net Income | -$18.62M | -$15.24M | -$12.68M | -$4.05M |
| EPS Diluted | -$0.64 | -$0.53 | -$0.45 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Standard Biotools Inc. · CIK 1162194 · Engraved from SEC EDGAR